GT BIOPHARMA, INC.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.69 | $-0.11 |
| FY2022 | $-6.55 | $-0.81 |
| FY2023 | $-1.88 | $-1.01 |
| FY2024 | $-2.31 | $-1.24 |
| FY2025 | $-6.68 | $-1.91 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-0.69 | $-0.11 |
| FY2022 | $-6.55 | $-0.81 |
| FY2023 | $-1.88 | $-1.01 |
| FY2024 | $-2.31 | $-1.24 |
| FY2025 | $-6.68 | $-1.91 |